Company Overview and News

 
Primary Opinion enters dairy food sector, now targets funding

2017-11-15 proactiveinvestors.com.au
Primary Opinion Ltd (ASX:POP) has signed an agreement to spend $34 million to purchase 100% of B-d. Farm Paris Creek (Paris Creek), an Australian organic-biodynamic dairy food and beverage businesses.
Upvote Downvote

 
Primary Opinion is an ASX Volume Leader as market embraces Laura McBain

2017-08-14 proactiveinvestors.com.au
Atlas Iron Ltd (ASX:AGO) is once again today's most liquid stock, with 49 million shares changing hands by the afternoon, although there has been no change in the $0.019 share price.
Upvote Downvote

 
Former Bellamy's boss Laura McBain's new recipe for success with Maggie Beer business

2017-08-08 smh.com.au
Former Bellamy's boss Laura McBain has downed the gardening shears and taken up a new job at Primary Opinion – the ASX-listed journeyman that has now pinned its hopes to a 48 per cent stake in Maggie Beer's food business. And now a rock star CEO.
Upvote Downvote

 
Former Bellamy's boss Laura McBain's new recipe for success with Maggie Beer business

2017-08-08 theage.com.au
Former Bellamy's boss Laura McBain has downed the gardening shears and taken up a new job at Primary Opinion – the ASX-listed journeyman that has now pinned its hopes to a 48 per cent stake in Maggie Beer's food business. And now a rock star CEO.
Upvote Downvote

 
Primary Opinion Ltd: shareholders to vote on company direction

2016-06-24 proactiveinvestors.com.au
Primary Opinion Limited (ASX:POP) recently entered into discussion to acquire a 48% equity stake in  a well-known Australian media and cooking identity, Maggie Beer's premium food products company, for $15 million. Maggie Beer Products Pty Ltd makes premium food products under the Maggie Beer brand for retailing in Australia through supermarkets, gourmet food stores and online channels. The ASX has granted Primary Opinion a trading halt pending the release of the results of a general meeting of shareholders to be held today.
Upvote Downvote

 
Primary Opinion Ltd: shareholders to vote on company directions

2016-06-24 proactiveinvestors.com.au
Primary Opinion Limited (ASX:POP) recently entered into discussion to acquire a 48% equity stake in  a well-known Australian media and cooking identity, Maggie Beer's premium food products company, for $15 million. Maggie Beer Products Pty Ltd makes premium food products under the Maggie Beer brand for retailing in Australia through supermarkets, gourmet food stores and online channels. The ASX has granted Primary Opinion a trading halt pending the release of the results of a general meeting of shareholders to be held today.
Upvote Downvote

 
New Maggie Beer chair Tony Robinson keen to push into a willing Chinese market

2016-05-23 theage.com.au
The chairman of the ASX-listed entity buying 48 per cent of celebrity chef Maggie Beer's business is a veteran in the financial services sector who is now going from investment platforms to quince paste.
Upvote Downvote

 
New Maggie Beer chair Tony Robinson keen to push into a willing Chinese market

2016-05-23 smh.com.au
The chairman of the ASX-listed entity buying 48 per cent of celebrity chef Maggie Beer's business is a veteran in the financial services sector who is now going from investment platforms to quince paste.
Upvote Downvote

 
Primary Opinion Ltd goes into business with Maggie Beer

2016-05-10 proactiveinvestors.com.au
Primary Opinion Ltd (ASX:POP) will acquire a 48% equity stake in well known Australian media and cooking identity, Maggie Beer's premium food products company for $15 million. MBP makes premium food products under the Maggie Beer brand for retailing in Australia through supermarkets, gourmet food stores and online channels. The company aims to raise up to $25 million in new capital to fund its investment in MBP and to provide the company with additional capital to explore opportunities in the food and beverage industry.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...